Stock listing
LSL Stock Price, News, Filings & Events — Lsl Pharma Group Inc
Selected listing: LSL · TSXV · CAD · CA
This page tracks Lsl Pharma Group Inc's LSL:TSXV listing on TSXV in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LSL:TSXV. LSL:TSXV is the stock-level entry point for investors researching Lsl Pharma Group Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lsl Pharma Group Inc is a publicly traded company on the Canadian market under the ticker LSL. With a market capitalization of approximately CAD 31.12 million, the company is focused on the pharmaceutical sector. Lsl Pharma Group aims to develop innovative solutions within its industry.

- Ticker
- LSL:TSXV
- Asset type
- Stock
- Market cap
- $32.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSXV
- Currency
- CAD
Lsl Pharma Group Inc LSL:TSXV stock context
This page tracks Lsl Pharma Group Inc's LSL:TSXV listing on TSXV in CAD for CA, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following LSL:TSXV. LSL:TSXV is the stock-level entry point for investors researching Lsl Pharma Group Inc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Lsl Pharma Group Inc is a publicly traded company on the Canadian market under the ticker LSL. With a market capitalization of approximately CAD 31.12 million, the company is focused on the pharmaceutical sector. Lsl Pharma Group aims to develop innovative solutions within its industry.
Latest news from Lsl Pharma Group Inc
LSL PHARMA GROUP REPORTS RECORD REVENUES AND SECOND QUARTER 2026 RESULTS
August 25, 2026
LSL PHARMA GROUP PROVIDES UPDATE ON STERI-MED PHARMA MANUFACTURING OPERATIONS AND GRANTS COMPENSATION STOCK OPTIONS
July 6, 2026
LSL PHARMA GROUP SECURES NEW STERI-MED COMMERCIAL AGREEMENTS EXPECTED TO GENERATE OVER $4 MILLION IN RECURRING ANNUAL REVENUES AND APPOIN...
May 28, 2026
LSL PHARMA GROUP REPORTS RECORD REVENUES AND FIRST QUARTER 2026 RESULTS
May 25, 2026
LSL PHARMA GROUP REPORTS ITS FOURTH QUARTER AND YEAR-END 2025 RESULTS
April 30, 2026
Research Lsl Pharma Group Inc
Lsl Pharma Group Inc investor report
Review AI stock analysis and investor report context for LSL:TSXV.
Lsl Pharma Group Inc company profile
View the public company page for Lsl Pharma Group Inc on 6ix.
Lsl Pharma Group Inc news
Read company news and market updates connected to Lsl Pharma Group Inc.
Lsl Pharma Group Inc investor events
Find investor webinars, events, and replay context for Lsl Pharma Group Inc.